Bioequivalence Study: Clinical Trials

11 trials for Bioequivalence Study, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

11 completed. 11 Phase 1.

By phase and status

PhaseTrialsStatus
Phase 111Completed 11

Follow Bioequivalence Study: new trials by email Literature Review of Bioequivalence Study trials Research Report on Bioequivalence Study

Trials (filtered) newest first · largest first

All 11 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Bioequivalence Study of Spironolactone Tablets in Healthy Subjects
Spironolactone Tablets (Test), Spironolactone Tablets (Reference) - Bioequivalence Study
Phase 1CompletedSPH Sine Pharmaceutical Laboratories Co., Ltd.642023-03-222024-08-30
Bioequivalence Study of DelanzoᵀᴹDR 60mg (Dexlansoprazole) Capsule With Dexilant® 60mg (Dexlansoprazole) Capsule in Healthy Pakistani Subjects.
Dexlansoprazole - Healthy, Bioequivalence Study
Phase 1CompletedUniversity of Karachi602021-09-182023-11-29
Bioequivalence Study of Mofest® 400mg (Moxifloxacin) Tablet With Avelox® 400mg (Moxifloxacin) Tablet in Healthy Pakistani Subjects
Moxifloxacin 400mg - Healthy Individuals, Bioequivalence Study
Phase 1CompletedUniversity of Karachi382021-05-282022-09-07
Bioequivalence Study of NPC-12 (Sirolimus) Granules and Tablets
sirolimus - Bioequivalence Study
Phase 1CompletedNobelpharma102018-12-052019-02-25
A Phase 1 Bioequivalence Study of a Test Tablet Formulation of Ravidasvir With the Reference Tablet Formulation of Ravidasvir Study
Ravidasvir test formulation produced by Doppel, Ravidasvir reference formulation produced by EEPI - Bioequivalence Study
Phase 1CompletedDrugs for Neglected Diseases372018-06-052020-01-31
Bio-equivalence Vasoconstriction Activity Study for Topically Applied Clocortolone Pivalate 0.1% Cream
Clocortolone Pivalate - Bioequivalence Study
Phase 1CompletedSun Pharmaceutical Industries, Inc.1242018-03-022020-04-24
Comparative Bioavailability and Local Tolerability of Two Topical Diclofenac Plasters Applied Once and Twice a Day
Diclofenac Sodium 140mg Medicated Plaster, Flector® topical plaster containing 180 mg of diclofenac hydroxyethylpyrrolidine equivalent to 140 mg of sodium diclofenac - Bioequivalence Study
Phase 1CompletedFidia Farmaceutici s.p.a.522017-11-282020-10-14
Bioequivalence Study of Gefitinib Tablets Under Fasting Conditions
Gefitinib Tablet 250mg of Hunan Kelun, Iressa® Tablet 250mg of AZN - Bioequivalence Study
Phase 1CompletedHunan Kelun Pharmaceutical Co., Ltd.382016-09-082026-05-26
Bioequivalence Study of Klaribact (Clarithromycin) 500 mg, Film Coated Tablet
Klaribact 500 mg Clarithromycin Tablet, Klaricid 500 mg Clarithromycin Tablet - Healthy Volunteers, Bioequivalence Study
Phase 1CompletedUniversity of Karachi242012-10-232022-09-07
Bioequivalence Study Comparing D961H Sachet and D961H Capsule in Japanese Healthy Male Subjects
D961H Sachet 20 mg, D961H HPMC capsule 20 mg - Bioequivalence Study
Phase 1CompletedAstraZeneca712012-05-012012-12-12
Study to Assess the Bioequivalence Between D961S and Esomeprazole/Buffered Acetylsalicylic Acid (ASA) in Japanese Healthy Male Subjects
D961S, Esomeprazole, Buffered acetylsalicylic acid - Bioequivalence Study
Phase 1CompletedAstraZeneca772012-01-012012-04-09

Interventions

Esomeprazole (2)  ·  Capsules (1)  ·  Clarithromycin (1)  ·  Dexlansoprazole (1)  ·  Diclofenac (1)  ·  Gefitinib (1)  ·  Hardness (1)  ·  Moxifloxacin (1)  ·  Sirolimus (1)  ·  Spironolactone (1)  ·  clocortolone (1)  ·  clocortolone pivalate (1)  ·  diclofenac hydroxyethylpyrrolidine (1)

Sponsors

University of Karachi (3)  ·  AstraZeneca (2)  ·  Drugs for Neglected Diseases (1)  ·  Fidia Farmaceutici s.p.a. (1)  ·  Hunan Kelun Pharmaceutical Co., Ltd. (1)  ·  Nobelpharma (1)  ·  SPH Sine Pharmaceutical Laboratories Co., Ltd. (1)  ·  Sun Pharmaceutical Industries, Inc. (1)

Countries

Japan (3)  ·  Pakistan (3)  ·  China (1)  ·  Italy (1)  ·  Malaysia (1)  ·  United States (1)

Top investigators

Prof. Dr. Muhammad R Shah, PhD (3)  ·  Damenthi Nair, MD (1)  ·  Masanari Shiramoto (1)  ·  Masataka Date (1)  ·  Nicola Giordan (1)